SOURCE: PHT Corporation

June 19, 2008 09:42 ET

PHT and Clients Convene to Discuss PRO Validation, Integrity of Electronic Records, and Optimized Trial Designs at European User Group Meeting

Fifth Annual Meeting of Pharmaceutical Innovators Proves Most Successful Yet

BOSTON, MA--(Marketwire - June 19, 2008) - PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 350 clinical trials worldwide, welcomed industry thought leaders to its fifth annual European User Group Meeting, which clients ranked as the best PHT ePRO meeting they have ever attended. Clients in attendance included Lundbeck, Novartis, Philip Morris International, Pierre Fabre, Roche, Servier and Wyeth.

"The PHT European User Group Meeting features excellent presentations including special case studies," noted Bruno Thédenat, Technology Project Manager at Wyeth Pharmaceuticals. "The meeting is a unique opportunity to have open conversations about ePRO experiences with PHT and other pharmaceutical companies. I look forward to next year."

The two-day agenda included topics such as subject safety, PRO validation, data analysis and trial design. Guest speakers highlighted experiences conducting ePRO trials and the site user's perspective on eDiaries.

Conference attendees also said they enjoyed the interactive Breakout Sessions which explored key topics in eClinical research in great detail with subject matter experts both from PHT and from the client community. Participants selected their topics of interest and were encouraged to brainstorm future enhancements and requirements in these interactive and dedicated sessions.

PHT executives in attendance included Phil Lee, President and CEO; Stephen Raymond, PhD, Founder and Chief Scientific and Quality Officer; Linda Beneze, Vice President of Sales and Client Services; Sheila Rocchio, VP of Marketing; Ian McLeod, VP of Development; Jodi Holman, Director of Customer Operations; and Dwight Cooper, Global Director, Technical Services.

"Each year, our European User Group Meeting is a key opportunity for clients to learn from each other and to affect our development strategy," said Phil Lee, PHT President and CEO. "The world's leading trial sponsors have established PHT products and services as de facto standards in ePRO based on significant improvements they deliver in patient safety, data quality and trial management efficiencies. These meetings are essential for us to maintain our strong client relationships through the open exchange of ideas and thought-leadership."

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 350 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time stamped assessments with minimal respondent burden, transmitted over reliable analog and wireless global technologies, sponsors are able to run smaller and more conclusive clinical research programs. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least seven known NDA approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information